Life Healthcare Group Holdings (LHC) Stock Overview
An investment holding company, operates as a private healthcare company in Southern Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
LHC Community Fair Values
Create NarrativeSee what 20 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Life Healthcare Group Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R10.61 |
| 52 Week High | R14.59 |
| 52 Week Low | R10.00 |
| Beta | 0.074 |
| 1 Month Change | 4.12% |
| 3 Month Change | -13.25% |
| 1 Year Change | -24.43% |
| 3 Year Change | -48.22% |
| 5 Year Change | -54.03% |
| Change since IPO | -21.41% |
Recent News & Updates
Narrative Update • Jun 23
LHC: Dividend Income Will Support Attractive Long Term Upside Potential
Analysts have trimmed their price target for Life Healthcare Group Holdings to ZAR12.43 from ZAR12.86, reflecting updated assumptions for the discount rate, revenue growth, profit margins and future P/E multiples. What’s in the News for Life Healthcare Group Holdings Life Healthcare Group Holdings approved an interim gross cash dividend of ZAR0.23 per ordinary share, declared from income reserves and subject to a 20% South African dividend withholding tax for non exempt shareholders, resulting in a net dividend of ZAR0.184 per share.Narrative Update • Jun 05
LHC: Dividend Payout And Steady Assumptions Will Support Future Upside Potential
Analysts have kept the fair value estimate for Life Healthcare Group Holdings steady at ZAR12.86. Updated assumptions include slightly adjusted discount rate, revenue growth, profit margin and forward P/E inputs, which guide their refreshed price target work.Narrative Update • May 19
LHC: Increasing Minority Ownership And Stable Metrics Will Support Future Upside Potential
Analysts have kept their ZAR12.86 price target for Life Healthcare Group Holdings broadly unchanged, citing stable assumptions on the discount rate, revenue, profit margin and forward P/E as the basis for maintaining their view. What's in the News An undisclosed buyer acquired an additional minority stake in Life Healthcare Group Holdings on March 6, 2026, increasing its exposure to the company.Recent updates
Narrative Update • Jun 23
LHC: Dividend Income Will Support Attractive Long Term Upside Potential
Analysts have trimmed their price target for Life Healthcare Group Holdings to ZAR12.43 from ZAR12.86, reflecting updated assumptions for the discount rate, revenue growth, profit margins and future P/E multiples. What’s in the News for Life Healthcare Group Holdings Life Healthcare Group Holdings approved an interim gross cash dividend of ZAR0.23 per ordinary share, declared from income reserves and subject to a 20% South African dividend withholding tax for non exempt shareholders, resulting in a net dividend of ZAR0.184 per share.Narrative Update • Jun 05
LHC: Dividend Payout And Steady Assumptions Will Support Future Upside Potential
Analysts have kept the fair value estimate for Life Healthcare Group Holdings steady at ZAR12.86. Updated assumptions include slightly adjusted discount rate, revenue growth, profit margin and forward P/E inputs, which guide their refreshed price target work.Narrative Update • May 19
LHC: Increasing Minority Ownership And Stable Metrics Will Support Future Upside Potential
Analysts have kept their ZAR12.86 price target for Life Healthcare Group Holdings broadly unchanged, citing stable assumptions on the discount rate, revenue, profit margin and forward P/E as the basis for maintaining their view. What's in the News An undisclosed buyer acquired an additional minority stake in Life Healthcare Group Holdings on March 6, 2026, increasing its exposure to the company.Narrative Update • May 01
LHC: Stable Assumptions And Growing Minority Stakes Will Shape Future Returns
Analysts have kept their ZAR 12.86 price target on Life Healthcare Group Holdings unchanged, citing stable assumptions for the discount rate, revenue growth, profit margin and future P/E as the basis for maintaining their view. What's in the News Clients of Ninety One SA (Pty) Ltd.
Narrative Update • Apr 15
LHC: JPMorgan Upgrade And Earnings Resilience Will Shape Future Share Performance
Analysts have raised their price target on Life Healthcare Group Holdings to ZAR13.70, citing slightly higher assumptions for long term revenue growth and profit margins, as well as a modestly lower future P/E multiple, as reflected in recent research updates such as the JPMorgan upgrade. Analyst Commentary Recent research points to a more constructive tone around Life Healthcare Group Holdings, with the ZAR13.70 price target framed as consistent with slightly higher assumptions for long term revenue growth and profit margins, balanced by a modestly lower future P/E multiple.Narrative Update • Apr 01
LHC: JPMorgan Upgrade And Margin Improvements Will Support Future Upside
Analysts have modestly lifted their price target for Life Healthcare Group Holdings to ZAR13.70. This reflects updated assumptions for slightly higher revenue growth, firmer profit margins and a marginally lower future P/E, as highlighted in recent Street research.Narrative Update • Mar 18
LHC: JPMorgan Upgrade And Institutional Buying Will Support Future Upside
Analysts have adjusted their ZAR price target for Life Healthcare Group Holdings to ZAR13.70, reflecting updated assumptions on revenue growth, profit margins, and future P/E following recent supportive research commentary, including the latest upgrade from JPMorgan. Analyst Commentary Bullish analysts are pointing to the recent ZAR13.70 price target as a sign of growing confidence in Life Healthcare Group Holdings' ability to support its current valuation through cash flow and earnings delivery.Narrative Update • Mar 04
LHC: JPMorgan Upgrade And Margin Resilience Will Support Future Return Potential
Narrative update on Life Healthcare Group Holdings Analysts have lifted their price target on Life Healthcare Group Holdings to ZAR12.86. The change is linked to updated views on its fair value, discount rate, revenue growth, profit margin and future P/E assumptions reflected in recent research such as the JPMorgan upgrade.Narrative Update • Feb 18
LHC: JPMorgan Upgrade And Dividend Will Support Future Return Potential
Analysts have nudged their ZAR fair value estimate for Life Healthcare Group Holdings from ZAR12.90 to ZAR12.86, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E expectations following recent supportive Street research, including an upgrade highlighted by JPMorgan. Analyst Commentary Bullish Takeaways Bullish analysts point to the recent JPMorgan upgrade as a signal that the current ZAR12.86 fair value still leaves room for upside if the group executes consistently on its core healthcare operations.Narrative Update • Feb 04
LHC: JPMorgan Upgrade And Dividend Policy Will Support Future Upside Potential
Analysts have modestly lifted their price target on Life Healthcare Group Holdings to R13.70, citing slightly higher assumptions for revenue growth, profit margins and a marginally lower forward P/E multiple as key drivers of the updated view. Analyst Commentary Recent commentary around Life Healthcare Group Holdings has turned more positive, with some bullish analysts pointing to a more supportive risk reward profile at the updated R13.70 price target.Narrative Update • Jan 21
LHC: JPMorgan Upgrade And Dividend Will Support Future Re-Rating Potential
Analysts have trimmed their price target on Life Healthcare Group Holdings to R13.70 from R14.50. They cite updated assumptions on long term revenue growth, profit margins and future P/E multiples following recent research updates.Narrative Update • Jan 05
LHC: Dividend Declaration Will Support Confidence Despite Revised Earnings Guidance
Analysts have cut their price target on Life Healthcare Group Holdings from R18.60 to R14.50, pointing to updated assumptions that include a revised discount rate, adjusted revenue growth and profit margin expectations, and a lower forward P/E multiple. What's in the News The board approved a final gross cash dividend of R0.35 per ordinary share, declared from income reserves and subject to a 20% South African dividend withholding tax for shareholders who are not exempt, resulting in a net dividend of R0.28 per share.Narrative Update • Dec 16
LHC: Dividend Strength Is Expected To Drive Attractive Future Returns
Analysts have nudged their price target on Life Healthcare Group Holdings slightly lower, from R13.78 to R12.90. They have factored more muted revenue growth, softer profit margin expectations, and a higher future price to earnings multiple into their updated valuation models.Narrative Update • Dec 02
LHC: Dividend Declaration And Margin Expansion Will Drive Outperformance
Analysts have raised their price target for Life Healthcare Group Holdings slightly, increasing it from R13.76 to R13.78. This adjustment is based on improved expectations for revenue growth and profit margins.Narrative Update • Nov 18
LHC: Future Earnings Will Improve Margins Despite Reduced Revenue Expectations
Analysts have lowered their price target for Life Healthcare Group Holdings from R15.44 to R13.76. This adjustment reflects slightly reduced expectations for revenue growth and profit margins.
New Narrative • Mar 17
Expanding NeuraCeq Sales And Southern Africa Hospitals Will Improve Future Market Position
Expansion in Southern Africa and investments in high-margin imaging services are expected to significantly boost revenue and future earnings.Analysis Article • Aug 05
Here's What's Concerning About Life Healthcare Group Holdings' (JSE:LHC) Returns On Capital
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...Analysis Article • May 30
Life Healthcare Group Holdings (JSE:LHC) Is Increasing Its Dividend To ZAR0.17
The board of Life Healthcare Group Holdings Limited ( JSE:LHC ) has announced that it will be paying its dividend of...Analysis Article • Apr 20
Life Healthcare Group Holdings (JSE:LHC) Could Be Struggling To Allocate Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...Analysis Article • Mar 18
Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analysis Article • Dec 24
Life Healthcare Group Holdings (JSE:LHC) Will Want To Turn Around Its Return Trends
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...Analysis Article • Nov 24
We Think That There Are More Issues For Life Healthcare Group Holdings (JSE:LHC) Than Just Sluggish Earnings
Last week's earnings announcement from Life Healthcare Group Holdings Limited ( JSE:LHC ) was disappointing to...Analysis Article • Nov 23
Life Healthcare Group Holdings' (JSE:LHC) Dividend Will Be ZAR0.25
Life Healthcare Group Holdings Limited ( JSE:LHC ) has announced that it will pay a dividend of ZAR0.25 per share on...Analysis Article • Sep 14
An Intrinsic Calculation For Life Healthcare Group Holdings Limited (JSE:LHC) Suggests It's 49% Undervalued
Does the September share price for Life Healthcare Group Holdings Limited ( JSE:LHC ) reflect what it's really worth...Analysis Article • Aug 15
Is Life Healthcare Group Holdings (JSE:LHC) Using Too Much Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analysis Article • Jul 31
Returns On Capital Signal Tricky Times Ahead For Life Healthcare Group Holdings (JSE:LHC)
To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...Shareholder Returns
| LHC | ZA Healthcare | ZA Market | |
|---|---|---|---|
| 7D | -0.6% | -0.06% | -1.7% |
| 1Y | -24.4% | 0.6% | 9.8% |
Return vs Industry: LHC underperformed the ZA Healthcare industry which returned 0.6% over the past year.
Return vs Market: LHC underperformed the ZA Market which returned 9.8% over the past year.
Price Volatility
| LHC volatility | |
|---|---|
| LHC Average Weekly Movement | 4.5% |
| Healthcare Industry Average Movement | 4.8% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in ZA Market | 9.6% |
| 10% least volatile stocks in ZA Market | 2.7% |
Stable Share Price: LHC has not had significant price volatility in the past 3 months compared to the ZA market.
Volatility Over Time: LHC's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | n/a | Peter Wharton-Hood | www.lifehealthcare.co.za |
Life Healthcare Group Holdings Limited, an investment holding company, operates as a private healthcare company in Southern Africa. It operates through Southern Africa – Hospitals Services, Southern Africa - Complementary Services, Southern Africa - Healthcare Services, and International segments. The company operates acute hospitals; and Life Nkanyisa care centres that provide long-term chronic mental healthcare, frail care rehabilitation, step-down care, correctional services, primary healthcare, and substance abuse recovery programme services to patients in the public sector.
Life Healthcare Group Holdings Limited Fundamentals Summary
| LHC fundamental statistics | |
|---|---|
| Market cap | R15.18b |
| Earnings (TTM) | R1.34b |
| Revenue (TTM) | R25.68b |
11.3x
P/E Ratio0.6x
P/S RatioIs LHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LHC income statement (TTM) | |
|---|---|
| Revenue | R25.68b |
| Cost of Revenue | R18.51b |
| Gross Profit | R7.17b |
| Other Expenses | R5.83b |
| Earnings | R1.34b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Nov 26, 2026
| Earnings per share (EPS) | 0.94 |
| Gross Margin | 27.93% |
| Net Profit Margin | 5.23% |
| Debt/Equity Ratio | 40.3% |
How did LHC perform over the long term?
See historical performance and comparisonDividends
6.6%
Current Dividend Yield62%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/10 01:31 |
| End of Day Share Price | 2026/07/09 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Life Healthcare Group Holdings Limited is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Rendani Magalela | Absa Bank Limited |
| Sean Ungerer | Arqaam Capital Research Offshore S.A.L. |
| Simon Mather | Barclays |